Jubilant Ingrevia informs about outcome of board meeting

22 Oct 2024 Evaluate
Pursuant to the provisions of Regulation 33 and 52 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’) and SEBI Circular No. SEBI/HO/DDHS/DDHS_Div1/P/CIR/2022/0000000103 (as amended), Jubilant Ingrevia has informed that the Board of Directors of the Company has, at its meeting held today on Tuesday, October 22, 2024 at 10:25 am that concluded at 02:00 pm, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half-year ended September 30, 2024 and Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter and half year; Pursuant to applicable provisions of the Listing Regulations, it has enclosed the following: The Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2024; 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter and half-year.

The above information is a part of company’s filings submitted to BSE.

Jubilant Ingrevia Share Price

707.30 31.65 (4.68%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3899.65
Tata Chemicals 761.20
SRF 3090.15
Pidilite Inds. 1459.30
Deepak Nitrite 1666.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×